Developed by Professor Keith Wesnes, the CDR System™ has become the industry standard for automated assessment of cognitive function in clinical trials for the last 20 years.
Supported by an unparalleled publication record and the most comprehensive neuropsychopharmacology databases ever assembled, the CDR System provides you with the most sensitive set of tests ever developed to assess improvements and impairments in cognitive function.
The CDR System assesses the major domains of cognitive function that are vulnerable to aging, fatigue, disease, pathology, trauma, diet and pharmaceuticals. Used in more than 1,200 trials across 50 indications and available in over 30 languages, the CDR System works in all clinical settings with any patient population throughout the drug development process. Core assessments can be completed in less than 20 minutes and can be administered by non-specialists with brief training. Data is automatically and securely recorded and uploaded directly into our databases, readily available for your review.
In addition to assessing the safety of new treatments, the CDR System is widely used in the rapidly expanding field of identifying cognition enhancement. All CNS and most other medical disorders are associated with cognitive dysfunction, and novel medicines and devices used to treat these disorders have the opportunity to rectify these disease-induced cognitive impairments. Such data can be captured by the CDR System, providing you with valuable information of direct relevance to everyday behavior, self-care, quality of life and work productivity.
You’ll be able to:
- Characterize the cognitive effect of therapeutic substances
- Measure change in function with high degree of sensitivity
- Ensure continuity both within and between research programs
- Determine the cognitive potential and effect of therapeutic substances